← Leaderboards

Cecilia M Shikuma

University Of Hawaii At Manoa

Google Scholar ↗PubMed ↗ORCID ↗

$37,258,278

Attributed

$44,514,429

Total exposure

35

Grants

15

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.4M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$54,610,317 · 36

By mechanism

U54$18,536,220 · 5

R01$12,944,949 · 4

U01$10,843,491 · 10

UH3$3,711,764 · 1

UG3$3,015,250 · 1

U19$1,842,391 · 1

Top collaborators

Most similar at University Of Hawaii At Manoa

Same institution · by research overlap

Richard Yanagihara$13,189,615
Yoshitsugi Hokama$626,536
David Easa$3,471,972
Venkataraman Balaraman$3,445,737
Marjorie K Mau$10,877,688

Others in their field

Top investigators on “Clinical Research”

David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
Sonia M Thomas · Research Triangle Institute$700,865,642
Jeffrey P Krischer · University Of South Florida$611,867,176
Barton F Haynes · Duke University$538,862,577

Research focus

Clinical ResearchHiv InfectionsHawaiiResearch PersonnelHuman SubjectClinical TrialsProgramsBaseFundingAidsAids TherapyHuman Therapy EvaluationGrantCollaborationsCooperative StudyAcquired Immunodeficiency SyndromePathogenesisInflammationInflammatoryParticipantBloodMonocyteCytokineInstitution

Grant awards (108)

HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY$1,546,250

UH3 · FY2025 · MD · contact PI

Clinical Research and Regulatory Support Core$349,083

U54 · FY2025 · GM · contact PI

HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY$1,546,250

UH3 · FY2024 · MD · contact PI

HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY$619,264

UH3 · FY2024 · MD · contact PI

Clinical Research and Regulatory Support Core$368,494

U54 · FY2024 · GM · contact PI

HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY$1,493,500

UG3 · FY2023 · MD · contact PI

Clinical Research and Regulatory Support Core$326,205

U54 · FY2023 · GM · contact PI

HAWAII CLINICAL RESEARCH NETWORK FOR HEALTH EQUITY$1,521,750

UG3 · FY2022 · MD · contact PI

Clinical Research and Regulatory Support Core$325,490

U54 · FY2022 · GM · contact PI

Hawaii Interdisciplinary Mentored Career Development in HIV Co-Morbidities$316,218

K12 · FY2022 · HL · contact PI

Research Infrastructure Core$1,422,178

U54 · FY2021 · MD · contact PI

Hawaii Interdisciplinary Mentored Career Development in HIV Co-Morbidities$412,099

K12 · FY2021 · HL · contact PI

Clinical Research and Regulatory Support Core$322,812

U54 · FY2021 · GM · contact PI

Research Infrastructure Core$1,812,596

U54 · FY2020 · MD · contact PI

Hawaii Interdisciplinary Mentored Career Development in HIV Co-Morbidities$414,273

K12 · FY2020 · HL · contact PI

Research Infrastructure Core$1,862,950

U54 · FY2019 · MD · contact PI

Hawaii Interdisciplinary Mentored Career Development in HIV Co-Morbidities$315,486

K12 · FY2019 · HL · contact PI

Research Infrastructure Core$1,827,720

U54 · FY2018 · MD · contact PI

Maraviroc and NeuroAIDS Pathogenesis$628,325

R01 · FY2018 · MH

Hawaii Interdisciplinary Mentored Career Development in HIV Co-Morbidities$99,954

K12 · FY2018 · HL · contact PI

Research Infrastructure Core$2,218,535

U54 · FY2017 · MD · contact PI

Maraviroc and NeuroAIDS Pathogenesis$681,020

R01 · FY2017 · MH

Maraviroc and NeuroAIDS Pathogenesis$645,027

R01 · FY2016 · MH · contact PI

Maraviroc and NeuroAIDS Pathogenesis$141,735

R01 · FY2016 · MH · contact PI

Maraviroc and NeuroAIDS Pathogenesis$38,386

R01 · FY2016 · MH · contact PI

Maraviroc and NeuroAIDS Pathogenesis$651,150

R01 · FY2015 · MH · contact PI

Maraviroc and NeuroAIDS Pathogenesis$679,934

R01 · FY2014 · MH · contact PI

Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk$890,691

R01 · FY2012 · HL · contact PI

HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms$644,998

R01 · FY2012 · NS · contact PI

Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk$873,986

R01 · FY2011 · HL · contact PI

HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms$659,742

R01 · FY2011 · NS · contact PI

Clinical Studies$432,580

U19 · FY2011 · MH · contact PI

Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk$890,587

R01 · FY2010 · HL · contact PI

HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms$666,312

R01 · FY2010 · NS · contact PI

Clinical Studies$450,059

U19 · FY2010 · MH · contact PI

Role of macrophages in HIV Lipoatrophy$321,337

R01 · FY2010 · AI · contact PI

HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms$34,176

R01 · FY2010 · NS · contact PI

Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk$908,629

R01 · FY2009 · HL · contact PI

HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms$674,721

R01 · FY2009 · NS · contact PI

Clinical Studies$454,218

U19 · FY2009 · MH · contact PI

HIV RESEARCH CORE$402,713

P20 · FY2009 · RR · contact PI

Role of macrophages in HIV Lipoatrophy$324,582

R01 · FY2009 · AI · contact PI

Role of Oxidative Stress and Inflammation in HIV Cardiovascular Risk$903,615

R01 · FY2008 · HL · contact PI

HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms$689,796

R01 · FY2008 · NS · contact PI

Clinical Studies$342,685

U19 · FY2008 · MH · contact PI

Role of macrophages in HIV Lipoatrophy$324,582

R01 · FY2008 · AI · contact PI

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM$233,159

U01 · FY2008 · AI · contact PI

HIV RESEARCH CORE$178,065

P20 · FY2008 · RR · contact PI

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM$645,273

U01 · FY2007 · AI · contact PI

Role of macrophages in HIV Lipoatrophy$330,868

R01 · FY2007 · AI · contact PI

Clinical Studies$162,849

U19 · FY2007 · MH · contact PI

HIV RESEARCH CORE$119,138

P20 · FY2007 · RR · contact PI

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM$1,137,711

U01 · FY2006 · AI · contact PI

ACTIVITY 6: HAWAII HIV IMMUNOLOGY AND VACCINE CORE$581,504

G12 · FY2006 · RR · contact PI

Role of macrophages in HIV Lipoatrophy$340,750

R01 · FY2006 · AI · contact PI

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM$1,480,054

U01 · FY2005 · AI

University of Hawaii NeuroAIDS SNRP$1,351,061

U54 · FY2005 · NS

ACTIVITY 6: HAWAII HIV IMMUNOLOGY AND VACCINE CORE$390,714

G12 · FY2005 · RR

Mitochondrial Function and HIV Lipoatrophy$136,300

R21 · FY2005 · AI

STUDIES OF POTENTIAL THERAPEUTIC MODALITIES FOR HIV-ASSOCIATED LIPODYSTROPHY$9,163

P20 · FY2005 · RR

ALENDRONATE IN HIV-INFECTED SUBJECTS WITH DECREASED BMD RECEIVING CA AND VIT D$9,162

P20 · FY2005 · RR

ACTG A5084$9,162

P20 · FY2005 · RR

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM$1,480,467

U01 · FY2004 · AI

University of Hawaii NeuroAIDS SNRP$1,422,632

U54 · FY2004 · NS

Mitochondrial Function and HIV Lipoatrophy$238,525

R21 · FY2004 · AI

ACTG A5084$17,065

P20 · FY2004 · RR

ALENDRONATE IN HIV-INFECTED SUBJECTS WITH DECREASED BMD RECEIVING CA AND VIT D$17,065

P20 · FY2004 · RR

STUDIES OF POTENTIAL THERAPEUTIC MODALITIES FOR HIV-ASSOCIATED LIPODYSTROPHY$17,065

P20 · FY2004 · RR

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM$1,511,671

U01 · FY2003 · AI

University of Hawaii NeuroAIDS SNRP$1,356,831

U54 · FY2003 · NS

University of Hawaii NeuroAIDS SNRP$76,787

U54 · FY2003 · NS

University of Hawaii NeuroAIDS SNRP$30,000

U54 · FY2003 · NS

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM$1,367,841

U01 · FY2002 · AI

University of Hawaii NeuroAIDS SNRP$1,360,264

U54 · FY2002 · NS

HIV-Associated Lipodystrophy &Metabolic Abnormalities--Testosterone$173,158

U54 · FY2002 · RR

IMMUNOLOGY AND IMMUNE BASED THERAPY AGENDA$83,067

U01 · FY2002 · AI

CORE--ADVANCED TECHNOLOGY LABORATORIES$83,067

U01 · FY2002 · AI

OUTREACH AGENDA$83,067

U01 · FY2002 · AI

OUTCOMES COMMITTEE AGENDA$83,067

U01 · FY2002 · AI

WOMEN'S HEALTH AGENDA$83,067

U01 · FY2002 · AI

PHARMACOLOGY AGENDA$83,067

U01 · FY2002 · AI

NEUROLOGY AGENDA$83,067

U01 · FY2002 · AI

COMPLICATIONS OF HIV DISEASE AGENDA$83,067

U01 · FY2002 · AI

HIV DISEASE RESEARCH AGENDA$83,067

U01 · FY2002 · AI

University of Hawaii NeuroAIDS SNRP$6,815

U54 · FY2002 · NS

NIASPAN AND CO-FACTORS FOR LIPOATROPHY$0

P20 · FY2002 · MD

NIASPAN AND CO-FACTORS FOR LIPOATROPHY$0

P20 · FY2002 · MD

A3A: CLINICAL RETROVIROLOGY FOR HIV: HAWAII AIDS RESEARCH CONSORTIUM$0

G12 · FY2002 · RR

A3A: CLINICAL RETROVIROLOGY FOR HIV: HAWAII AIDS RESEARCH CONSORTIUM$0

G12 · FY2002 · RR

A3B: MOLEC EPIDEM OF HUMAN RETROVIRUS &EMERGING VIRUSES IN ASIA &PACIFIC: HIV$0

G12 · FY2002 · RR

A3B: MOLEC EPIDEM OF HUMAN RETROVIRUS &EMERGING VIRUSES IN ASIA &PACIFIC: HIV$0

G12 · FY2002 · RR

University of Hawaii NeuroAIDS SNRP$1,359,465

U54 · FY2001 · NS

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM$1,344,787

U01 · FY2001 · AI

HIV-Associated Lipodystrophy &Metabolic Abnormalities--Testosterone$173,158

U54 · FY2001 · RR

CORE--ADVANCED TECHNOLOGY LABORATORIES$0

U01 · FY2001 · AI

OUTREACH AGENDA$0

U01 · FY2001 · AI

OUTCOMES COMMITTEE AGENDA$0

U01 · FY2001 · AI

WOMEN'S HEALTH AGENDA$0

U01 · FY2001 · AI

PHARMACOLOGY AGENDA$0

U01 · FY2001 · AI

IMMUNOLOGY AND IMMUNE BASED THERAPY AGENDA$0

U01 · FY2001 · AI

NEUROLOGY AGENDA$0

U01 · FY2001 · AI

COMPLICATIONS OF HIV DISEASE AGENDA$0

U01 · FY2001 · AI

HIV DISEASE RESEARCH AGENDA$0

U01 · FY2001 · AI

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM$894,925

U01 · FY2000 · AI

HIV-Associated Lipodystrophy &Metabolic Abnormalities--Testosterone$389,986

U54 · FY2000 · RR

CHARACTERIZATION OF THE WASTING PROCESS IN HIV INFECTION$32,581

P20 · FY2000 · RR

A3B: MOLEC EPIDEM OF HUMAN RETROVIRUS &EMERGING VIRUSES IN ASIA &PACIFIC: HIV$0

G12 · FY2000 · RR

A3A: CLINICAL RETROVIROLOGY FOR HIV: HAWAII AIDS RESEARCH CONSORTIUM$0

G12 · FY2000 · RR